JAZZ - Jazz Pharmaceuticals plc (JAZZ) CEO Bruce Cozadd on Q3 2019 Results - Earnings Call Transcript
Jazz Pharmaceuticals plc (JAZZ)
Q3 2019 Results Earnings Conference Call
November 5, 2019, 04:30 PM ET
Company Participants
Katherine Littrell - Vice President, Investor Relations
Bruce Cozadd - Chairman and Chief Executive Officer
Daniel Swisher, Jr. - President and Chief Operating Officer
Robert Iannone - Executive Vice President, Research and Development
Michael Miller - Executive Vice President, U.S. Commercial
Allen Yang - Senior Vice President Clinical Development and Acting Chief Marketing Officer
Conference Call Participants
Brandon Folkes - Cantor Fitzgerald
Esther Rajavelu - Oppenheimer & Co. Inc.
Ami Fadia - SVB Leerink
Gary Nachman -